Skip to main content Scroll Top
Call us now
970.778.3753

Semaglutide- Low-dose GLP-1 Weight Loss or Tirzepatide (GLP1 and GIP)

Reducing hunger and cravings and preventing overeating.

Portfolio Item Semaglutide- Low-dose GLP-1 Weight Loss or Tirzepatide (GLP1 and GIP)

Vitamin Infusion

Semaglutide (GLP-1) or
Tirzepatide (GLP-1 and GIP) Treatment as Part
of a Medically Supervised
Weight-Management Program
$200

About Semaglutide, Tirzepatide  & GLP-1/GIP Therapy

Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and GIP receptors. 

They are both FDA-approved for type 2 diabetes and weight loss and, in specific formulations, for weight management in patients who meet the approved criteria.

In our clinic, semaglutide and tirzepatide are prescribed under medical supervision and individualized dosing. Some treatment approaches may involve off-label use, based on physician judgment and individual’s results

About Semaglutide, Tirzepatide  & GLP-1/GIP Therapy

Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on GLP-1 and GIP receptors. 

They are both FDA-approved for type 2 diabetes and weight loss and, in specific formulations, for weight management in patients who meet the approved criteria.

In our clinic, semaglutide and tirzepatide are prescribed under medical supervision and individualized dosing. Some treatment approaches may involve off-label use, based on physician judgment and individual’s results

  • Semaglutide and tirzepatide may help reduce appetite, increase feelings of fullness, and support weight loss when paired with healthy diet and physical activity. Outcomes vary from person to person. All treatment plans are monitored and adjusted for safety and effectiveness.
  • Combining diet & exercise, individuals can maintain the weight loss after short-term use. Contact us for details on getting started and special pricing
Schedule Your Treatment
i-yunmai-5jctAMjz21A-unsplash
Purple Block
dots-dark-small

About Semaglutide, Tirzepatide & GLP-1/GIP Therapy,

Semaglutide is a medication that acts on GLP-1 (glucagon-like peptide-1) receptors. It is FDA-approved for certain conditions such as type 2 diabetes and, in specific formulations, for weight management in patients meeting approved criteria.

Tirzepatide is a medication that acts on Glucose-dependent insulinotropic polypeptide receptors  : (GIP). stimulating GIP receptors enhances the body's natural response to food.

In our practice, we use semaglutide and tirzepatide under medical supervision, tailoring the dose to each patient’s health profile, goals, and response. Some uses may be off-label, depending on clinical judgment and patient eligibility.

How Our Program Works

1. Medical Evaluation & Screening
Before initiating therapy, our physician assesses your medical history, current health status, BMI, weight history, and potential contraindications. We review risks, benefits, and alternatives so you can make an informed decision.
 
2. Customized Dosing Plan
Based on your evaluation, we develop an individualized dosing schedule, starting at low doses and adjusting as tolerated—always under medical supervision.
 
3. Lifestyle Integration
Your treatment is designed to work alongside a structured diet and physical activity plan. Semaglutide and Tirzepatide are not standalone solutions; it performs best when paired with healthy habits.
 
4. Monitoring & Follow-Up
We schedule regular follow-up visits to monitor your progress, evaluate side effects, adjust dosing if needed, and perform any necessary lab work.
 
5. Ongoing Support
You’ll receive guidance on nutrition, behavioral techniques, and lifestyle changes to help optimize outcomes.
 
 
 

What You Might Expect

Semaglutide and tirzepatide may help reduce appetite, increase fullness, and support modest weight loss over time. However, responses differ among patients — factors like adherence, diet, exercise, and underlying health all influence results.

We do not guarantee specific weight outcomes.

Possible Side Effects & Risks

We review all risks during your consultation and continuously monitor your health throughout treatment.

As with any medication, semaglutide and tirzepatide can have side effects. Some common ones include:

• Nausea, vomiting, or indigestion
• Constipation or diarrhea
• Injection site irritation
• Headache
 

Rare but serious risks may include:

• Pancreatitis (inflammation of the pancreas)
• Gallbladder disease
• Kidney injury
• Possible risk of thyroid C-cell tumors (in animal studies)
 
 

Transparency & Product Information

Semaglutide and tirzepatide are commercially FDA-approved under brand names, such as Wegovy or Zepbound (weight management) and Ozempic or Mounjaro (type 2 diabetes); However our clinic offers a physician supervised program using compounded formulations that are not FDA-approved, and results can vary based on each individual’s health profile

Why Choose Our Clinic

• Medical oversight by licensed physicians with experience in GLP-1/GIP therapies
 
• Personalized dosing and adjustment according to your health needs
 
• Careful monitoring for safety and effectiveness
 
• Integration with comprehensive lifestyle support
 
 
 

Patient Agreement & Expectations

By participating in our semaglutide or tirzepatide program, you acknowledge:

• Results vary and are not uniform
 
• You will adhere to recommended diet, exercise, and follow-up
 
• You understand risks, possible side effects, and the off-label nature (if applicable)
 

• You will communicate any adverse symptoms immediately

Supportive Nutrients: Contains vitamin B to help promote additional nutritional support. Sometimes, amino acids may be offered to support general wellness.

  • Common: nausea, vomiting, constipation, diarrhea, indigestion, injection site reactions.
  • Rare but serious: pancreatitis, gallbladder disease, kidney injury, potential thyroid C-cell tumor risk (observed in animals).
  • All risks are reviewed in consultation, and patients are closely monitored.


“While semaglutide and tirzepatide are commercially FDA-approved under brand names such as Wegovy® and Zepbound (weight management) and Ozempic® and Mounjaro (type 2 diabetes), our clinic offers a physician-supervised program using compounded, low-dose semaglutide and tirzepatide when appropriate. Compounded formulations are not FDA-approved, and results can vary based on each individual’s health profile"